Relapse after methylprednisolone oral minipulse therapy in childhood vitiligo: A 12-month follow-up study
Background: Oral minipulse (OMP) therapy with methylprednisolone is presently one of the most common oral treatments used for progressive vitiligo in children. The treatment is usually given for a period of 6 months during which majority of patients are reported to go into remission. However, there...
Main Authors: | Imran Majid, Saher Imran |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: | |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2013;volume=58;issue=2;spage=113;epage=116;aulast=Majid |
Similar Items
-
Childhood vitiligo : Response to methylprednisolone oral minipulse therapy and topical fluticasone combination
by: Majid Imran, et al.
Published: (2009-01-01) -
A randomized controlled study to compare the efficacy of methotrexate vs. oral minipulse (betamethasone) along with NBUVB in patients with vitiligo vulgaris
by: Ashish Deshmukh, et al.
Published: (2020-01-01) -
Neuroretinitis with vitiligo: A rare case report
by: Anubhav Chauhan, et al.
Published: (2017-01-01) -
A comparative study in treatment of childhood vitiligo 0.03% tacrolimus versus 0.03% tacrolimus and topical steroids
by: Anandan Venkatesan, et al.
Published: (2021-01-01) -
Depigmentation therapy with Q-switched Nd: YAG laser in universal vitiligo
by: Imran Majid, et al.
Published: (2013-01-01)